Hangzhou Alltest Biotech Co Ltd - Class A

SHSE:688606 (China)   Class A
Â¥ 57.74 (+0.98%) May 31
24.78
P/B:
1.19
Market Cap:
Â¥ 4.58B ($ 632.10M)
Enterprise V:
Â¥ 1.89B ($ 261.06M)
Volume:
44.37M
Avg Vol (2M):
612.98K
Volume:
44.37M
Avg Vol (2M):
612.98K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hangzhou Alltest Biotech Co Ltd ( SHSE:688606 ) from 2021 to May 31 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hangzhou Alltest Biotech stock (SHSE:688606) PE ratio as of May 31 2024 is 24.78. More Details

Hangzhou Alltest Biotech Co Ltd (SHSE:688606) PE Ratio (TTM) Chart

To

Hangzhou Alltest Biotech Co Ltd (SHSE:688606) PE Ratio (TTM) Historical Data

Total 773
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 9
Hangzhou Alltest Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-31 24.8 2024-03-25 25.7
2024-05-31 24.8 2024-03-22 26.5
2024-05-30 24.5 2024-03-21 26.3
2024-05-29 24.4 2024-03-20 27.4
2024-05-28 24.3 2024-03-19 27.3
2024-05-27 24.5 2024-03-18 27.2
2024-05-24 24.1 2024-03-15 27.0
2024-05-23 24.2 2024-03-14 26.9
2024-05-22 24.9 2024-03-13 27.0
2024-05-21 24.4 2024-03-12 26.9
2024-05-20 24.8 2024-03-11 26.4
2024-05-17 24.7 2024-03-08 25.8
2024-05-16 25.4 2024-03-07 25.7
2024-05-15 25.8 2024-03-06 26.5
2024-05-14 26.3 2024-03-05 26.5
2024-05-13 27.2 2024-03-04 26.9
2024-05-10 28.1 2024-03-01 27.2
2024-05-09 28.6 2024-02-29 27.6
2024-05-08 29.0 2024-02-28 26.5
2024-05-07 29.0 2024-02-27 27.6
2024-05-06 29.4 2024-02-26 27.4
2024-04-30 28.5 2024-02-23 24.9
2024-04-29 29.1 2024-02-22 25.2
2024-04-26 32.2 2024-02-21 25.5
2024-04-25 31.8 2024-02-20 26.1
2024-04-24 30.8 2024-02-19 25.5
2024-04-23 30.6 2024-02-08 26.3
2024-04-22 29.9 2024-02-07 24.1
2024-04-19 31.8 2024-02-06 24.8
2024-04-18 31.2 2024-02-05 23.8
2024-04-17 30.5 2024-02-02 24.3
2024-04-16 27.8 2024-02-01 25.7
2024-04-15 29.5 2024-01-31 25.5
2024-04-12 29.5 2024-01-30 26.1
2024-04-11 28.9 2024-01-29 25.8
2024-04-10 28.8 2024-01-26 26.0
2024-04-09 29.4 2024-01-25 26.8
2024-04-08 29.4 2024-01-24 25.7
2024-04-03 27.0 2024-01-23 25.3
2024-04-02 24.9 2024-01-22 25.0
2024-04-01 24.6 2024-01-19 26.5
2024-03-29 25.1 2024-01-18 26.8
2024-03-28 25.6 2024-01-17 27.1
2024-03-27 25.6 2024-01-16 28.1
2024-03-26 25.6 2024-01-15 28.4

Hangzhou Alltest Biotech Co Ltd (SHSE:688606) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.